Drug Retail

JP Morgan has raised the price target on CVS Caremark Corporation (NYSE: CVS) from $42 to $43 and maintains its Overweight rating.

Cusick's Corner The market pulled back into the afternoon but never jeopardized any critical levels. Commodities bounced back today, especially as the Buck continued to pull back and the market was looking to get into some safety over the long weekend. Another positive point is that Copper,...

Shares of CVS Caremark Corporation (NYSE: CVS) are higher on the session by 2.07%, trading at $38.94. Overall call volume is now running at 3.70x the daily average, with 47% of all calls traded being purchases on the offer. 22,479 contracts have traded on the session so far. CVS Caremark...

Shares of MedcoHealth Solutions Inc. (NYSE: MHS) are down over 10% this morning after the company confirmed it had lost a contract with the U.S. Federal Worker Health-Benefit Contract to CVS Caremark (NYSE: CVS). The contract is worth $3 billion in 2012, almost 5% of the company's revenue. At...

CVS Caremark Corporation (NYSE: CVS) today announced that it has been awarded a three-year contract to provide integrated pharmacy benefit services for the Blue Cross and Blue Shield Government-wide Service Benefit Plan, also known as the Federal Employee Program, based on the best overall value...

At an event today, Google (NASDAQ: GOOG), Citi (NYSE: C), MasterCard (NYSE: MA), First Data and Sprint (NYSE: S) announced and demonstrated Google Wallet, an app that will make your phone your wallet so you can tap, pay and save money and time while you shop. For businesses, Google Wallet is an...

Joel Greenblatt, of Gotham Asset Management, spoke at the Ira Sohn Conference yesterday, and said that we have been in one continuing bubble since 2000, just different kinds of bubbles. Since 2000, we have experienced the Internet bubble, which led to the NASDAQ crashing some 50%, of which it...

According to a recent report, Goldman Sachs has removed Walgreen (NYSE: WAG) from America's Conviction List but still maintain a Buy rating and a $48.00 price target on the company. In the report, Goldman Sachs said, "We trim our August quarter forecast from Street-high, and now stand at Street...

According to a recent report by Citi, CVS Caremark (NYSE: CVS) was very optimistic at the 2011 Global Consumer Conference in NYC. At the conference, the company maintained focus on pharmacy growth, improving trends, and increasing customer service. Following the conference, Citi has reiterated the...

Goldman Sachs is raising its PT on Walgreen Companu (NYSE: WAG) to $48.

Johns Hopkins Medicine and Walgreens (NYSE: WAG) today announced they have entered into a wide-ranging agreement designed to promote collaboration on population-based research and to jointly review and develop protocols to improve outcomes of patients with chronic diseases. In addition, JHM and...

Graymark Healthcare, Inc. (NASDAQ: GRMH) reported that its Board of Directors approved a 1-for-4 reverse stock split, which will be effective after the close of the market on June 3, 2011. The 1-for-4 reverse stock split will automatically convert all shares of the company's stock issued and...

Polo Ralph Lauren Corp (NYSE: RL) is expected to post its Q4 earnings at $0.79 per share on revenue of $1.39 billion. Hormel Foods Corp (NYSE: HRL) is estimated to report its Q2 earnings at $0.40 per share on revenue of $1.82 billion. Netapp Inc (NASDAQ: NTAP) is estimated to post its Q4 EPS at...

Graymark Healthcare, Inc. (NASDAQ: GRMH) has appointed Jamie Hopping as chairman of its board of directors, effective July 1, 2011. She will succeed Stanton Nelson, who will continue in his role as chief executive officer.

According to Jefferies, Walgreen (NYSE: WAG) were invited to management meetings. Jefferies said that it had the opportunity to host Walgreen management in KC and Houston and came away bullish. “While industry fundamentals should support a solid Rx business, the real opportunity appears to be in...